• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients
Conclusion: In this retrospective, single-center experience, undersized balloon angioplasty followed by Enterprise stent deployment appears technically feasible with a relatively low rate of complications for the treatment of complex symptomatic ICAS. Prospective, multicenter, randomized controlled trials against optimal medical management are warranted.
Source: BMC Neurology - October 8, 2015 Category: Neurology Authors: Zhengzhe FengGuoli DuanPing ZhangLei ChenYi XuBo HongWenyuan ZhaoJianmin LiuQinghai Huang Source Type: research

Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature
Conclusions: The authors have successfully demonstrated the safety and efficacy of using mixed vasopressin antagonist in treatment of stroke related brain edema, thereby showing its promise as an alternative anti-edema agent. Preliminary findings from this study suggest mixed vasopressin antagonism may have significant utility in the management of cerebral edema arising from cerebrovascular accident. Larger prospective studies are warranted to explore the role of conivaptan in the treatment of brain edema and neuroprotection.
Source: BMC Neurology - November 18, 2014 Category: Neurology Authors: Vishnumurthy HednaSharathchandra BidariDavid GubernickSaeed AnsariIrawan SatriotomoAsif KhanAdnan Qureshi Source Type: research